$バイオナノ・ジェノミクス(BNGO.US)$Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines Ogm and Artificial Intelligence
$バイオナノ・ジェノミクス(BNGO.US)$Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing Benzinga· just Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
$バイオナノ・ジェノミクス(BNGO.US)$ NEWS Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing Bionano Genomics, Inc. (BNGO) announced a study using optical genome mapping (OGM) and whole genome sequencing (WGS) to identify genetic variations in pediatric B-cell acute lymphoblastic leukemia. OGM and WGS together can reveal new therapeutic targets and improve personalized medicine ...
$バイオナノ・ジェノミクス(BNGO.US)$Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ System 4 MINUTES AGO, 8:00 AM EST VIA GLOBENEWSWIRE
Despite Bionano Genomics' robust revenue growth and future projections, its P/S ratio is surprisingly low, indicating investor skepticism about the company's ability to meet these expectations. The market seems to be factoring in certain risks, leading to investor hesitation.
バイオナノ・ジェノミクスに関するコメント
Update
Update
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
NEWS
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
Bionano Genomics, Inc. (BNGO) announced a study using optical genome mapping (OGM) and whole genome sequencing (WGS) to identify genetic variations in pediatric B-cell acute lymphoblastic leukemia. OGM and WGS together can reveal new therapeutic targets and improve personalized medicine ...
Looks like 2 ?
ME and BNGO
Update
Update
Benzinga· 8 mins ago
まだコメントはありません